1 (46, male) | Enterogenic HLA-B27 associated ReA | αβ CD8+ | CD8/1 | SFMC derived, TCR in colon, synovium, PB | 4 |
| | | CD8/1+ | | |
| | αβ CD8+ | CD8/2 | SFMC derived, TCR in colon, synovium, PB | |
| | | CD8/2+ | | |
| | αβ CD8+ | CD8/3 | SFMC derived | |
| | | CD8/3+ | | |
| | | | | |
2 (28, male) | Genitourinary Chlamydia trachomatis induced ReA | αβ CD4+ | CD4/1 | SFMC derived, DR4 restricted, specific for chlamydial pmpD | 7 |
| | CD4/1+ | | |
| | αβ CD4+ | CD4/2 | SFMC derived, DR4 restricted, specific for chlamydial omp2 | |
| | | CD4/2+ | | |
| | αβ CD4+ | CD4/3 | SFMC derived, DR4 restricted, specific for chlamydial Hsp60 | |
| | | CD4/3+ | | |
| | | | | |
3 (19, male) | Yersinia induced ReA | γδ+ | gd/1 | SFMC derived, enterobacteria reactive (Yersinia, Salmonella, E coli) | 6 |
| | | gd/1+ | | |
| | γδ+ | gd/2 | SFMC derived, enterobacteria reactive (Yersinia, Salmonella, E coli) | |
| | | gd/2+ | | |
| | γδ+ | gd/3 | SFMC derived, enterobacteria reactive (Yersinia, Salmonella, E coli) | |
| | | gd/3+ | | |